亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced nonsmall cell lung cancer

医学 阿列克替尼 队列 内科学 肺癌 雄激素 睾酮(贴片) 胃肠病学 癌症 间变性淋巴瘤激酶 肿瘤科 激素 恶性胸腔积液
作者
Emanuele Vita,Federico Monaca,Domenico Milardi,Luca Mastrantoni,Alessio Stefani,Edoardo Vergani,Jacopo Russo,D. Barone,Ileana Sparagna,A. Vitale,Alessandro Scala,Denis Occhipinti,Mariantonietta Di Salvatore,Alfredo Pontecorvi,Giampaolo Tortora,Emilio Bria
出处
期刊:Cancer [Wiley]
卷期号:130 (15): 2611-2620
标识
DOI:10.1002/cncr.35293
摘要

ABSTRACT Background It is reported that treatment with anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) induces hypogonadism both in male patients with ALK‐positive cancer and in murine models. Methods In this study, three groups, including an experimental group of male patients with ALK‐positive, advanced non–small cell lung cancer (ANSCLC) who were receiving alectinib (cohort A), a control group of female patients with ALK‐positive ANSCLC who were receiving alectinib (cohort B), and a control group of male patients with ALK‐negative ANSCLC (cohort C), prospectively underwent a full hormone assessment for androgen deficiency at 8 weeks after the start of treatment and in case of reported suspected symptoms. Patients with major sexual dysfunctions were referred to an endocrinologist. Results Ninety‐five patients were consecutively enrolled onto the study. Among sixty‐eight male patients, both median total testosterone levels (2.93 vs. 4.92 ng/ml; p = .0001) and free testosterone levels (0.11 vs. 0.17 pg/ml; p = .0002) were significantly lower in ALK‐positive ANSCLC patients in cohort A compared with ALK‐negative patients in cohort C; conversely, median FSH (10.32 vs. 17.52 mUI/ml; p = .0059) and LH levels (4.72 vs. 7.49 mUI/ml; p = .0131) were significantly higher in cohort C compared to cohort A. Median inhibin B levels were higher in ALK‐positive male patients (74.3 vs. 44.24 pg/ml; p = .0038), but all patients had inhibin B values within the normal range. The percentage of male patients who had positive scores on the Androgen Deficiency in Aging Males (ADAM) questionnaire was 62% in cohort A and 26.8% in cohort C, including eight patients who reported at least one major symptom and were referred to Andrology Unit. No significant differences in the endocrine assessment were reported between cohorts A and B. Conclusions Symptoms of androgen deficiency should be tracked in male patients with ALK‐positive ANSCLC who are receiving alectinib, and testosterone replacement should be considered, as appropriate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大方大船完成签到,获得积分10
7秒前
谦让幻珊发布了新的文献求助10
8秒前
温柔灵波完成签到 ,获得积分10
9秒前
田様应助科研通管家采纳,获得10
12秒前
李爱国应助科研通管家采纳,获得10
12秒前
12秒前
13秒前
可爱的函函应助谦让幻珊采纳,获得10
14秒前
ding应助江洋大盗采纳,获得10
19秒前
Song完成签到 ,获得积分10
19秒前
谦让幻珊完成签到,获得积分10
21秒前
嗨好发布了新的文献求助20
27秒前
33秒前
沈惠映完成签到 ,获得积分10
33秒前
39秒前
嗨好完成签到,获得积分10
39秒前
Isaac完成签到 ,获得积分10
41秒前
莹yy完成签到 ,获得积分10
41秒前
乐正亦寒完成签到 ,获得积分10
52秒前
斯文败类应助haha采纳,获得10
55秒前
Swear完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
JingjingYao发布了新的文献求助10
1分钟前
行舟完成签到 ,获得积分10
1分钟前
太清发布了新的文献求助10
1分钟前
江洋大盗发布了新的文献求助10
1分钟前
1分钟前
WWW完成签到 ,获得积分10
1分钟前
鲁丁丁发布了新的文献求助10
1分钟前
秋蚓完成签到 ,获得积分10
1分钟前
一切随风发布了新的文献求助50
1分钟前
超威蓝猫完成签到,获得积分10
1分钟前
ztayx完成签到 ,获得积分10
1分钟前
图治完成签到,获得积分10
1分钟前
rangersl1发布了新的文献求助10
1分钟前
1分钟前
图治发布了新的文献求助10
1分钟前
三横一竖发布了新的文献求助10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976619
求助须知:如何正确求助?哪些是违规求助? 3520720
关于积分的说明 11204567
捐赠科研通 3257359
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806613